Inventor · disambiguated record
Ercole Rao
Also filed as: RAO ERCOLE
24 granted patents·29 pending applications·188 citations·filing 2002–2025
95Inventor score
Top patents by PatentIndex Score
53 records- 0196US11192960B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2020·Granted Dec 7, 2021·6 cites·30 claims
- 0296US10882922B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2017·Granted Jan 5, 2021·20 cites·47 claims
- 0395US11779651B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2021·Granted Oct 10, 2023·2 cites·3 claims
- 0494US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 0594US9221917B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Dec 29, 2015·23 cites·21 claims
- 0694US9181349B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Nov 10, 2015·29 cites·26 claims
- 0794US8388965B2Antibodies that bind IL-4 and/or IL-13 and their usesRAO ERCOLE·Filed 2008·Granted Mar 5, 2013·56 cites·21 claims
- 0893US11453727B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2020·Granted Sep 27, 2022·2 cites·12 claims
- 0993US11129905B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2019·Granted Sep 28, 2021·6 cites·3 claims
- 1093US9738728B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 22, 2017·11 cites·26 claims
- 1192US9732162B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2013·Granted Aug 15, 2017·8 cites·37 claims
- 1291US2025313651A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2024·Application pending·0 cites
- 1386US10759871B2Antibodies that bind IL-4 and/or IL-13 and their usesSANOFI SA·Filed 2017·Granted Sep 1, 2020·1 cites·6 claims
- 1486US2025312475A1Bivalent, bispecific binding proteins for prevention or treatment of hiv infectionSANOFI SA·Filed 2024·Application pending·0 cites
- 1584US10626169B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2018·Granted Apr 21, 2020·8 cites·17 claims
- 1683US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 1782US12227573B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2023·Granted Feb 18, 2025·0 cites·45 claims
- 1882US2023235088A1Antibodies that bind il-4 and/or il-13 and their usesSANOFI SA·Filed 2022·Application pending·0 cites
- 1978US11820809B2Multispecific antibodies facilitating selective light chain pairingSANOFI SA·Filed 2017·Granted Nov 21, 2023·2 cites·14 claims
- 2076US10906978B2Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123SANOFI SA·Filed 2018·Granted Feb 2, 2021·1 cites·22 claims
- 2174US2024279362A1Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2024·Application pending·0 cites
- 2273US2021189011A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2020·Application pending·0 cites
- 2371US11965030B2Multispecific binding proteins with mutant fab domainsSANOFI SA·Filed 2019·Granted Apr 23, 2024·1 cites·15 claims
- 2471US2025250338A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 2571US2025250337A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 2669US11008389B2Uses of a dual V region antibody-like proteinSANOFI SA·Filed 2016·Granted May 18, 2021·1 cites·11 claims
- 2766US11932704B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2021·Granted Mar 19, 2024·0 cites·7 claims
- 2866US2023391888A1Pseudofab-based multispecific binding proteinsSANOFI SA·Filed 2023·Application pending·0 cites
- 2965US2018155450A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2017·Application pending·0 cites
- 3063US2021292423A1Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123SANOFI SA·Filed 2021·Application pending·0 cites
- 3162US2024262923A1Anti-pd-1×4-1bb binding proteinsGENZYME CORP·Filed 2023·Application pending·0 cites
- 3261US11739160B2PseudoFab-based multispecific binding proteinsSANOFI SA·Filed 2019·Granted Aug 29, 2023·0 cites·36 claims
- 3361US2021221882A1Uses of a dual v region antibody-like proteinSANOFI SA·Filed 2021·Application pending·0 cites
- 3460US2016200811A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2015·Application pending·0 cites
- 3560US2012251541A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 3659US2013209469A1Antibodies that bind il-4 and/or il-13 and their usesRAO ERCOLE·Filed 2013·Application pending·0 cites
- 3759US2024018201A1Methods for purification of multi-specific antibodiesSANOFI SA·Filed 2023·Application pending·0 cites
- 3857US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 3957US2019054182A1Trispecific and/or trivalent binding proteins for prevention or treatment of hiv infectionSANOFI SA·Filed 2016·Application pending·0 cites
- 4056US2018236033A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2018·Application pending·0 cites
- 4154US2024043522A1Effectorless fc moleculesSANOFI SA·Filed 2021·Application pending·0 cites
- 4253US2023103563A1Split ch2 domainsSANOFI SA·Filed 2021·Application pending·0 cites
- 4352US2023279151A1Protease-processed moleculesSANOFI SA·Filed 2021·Application pending·0 cites
- 4450US2016279199A1Pharmaceutical composition for treating a metabolic syndromeSANOFI SA·Filed 2016·Application pending·0 cites
- 4549US2013203651A1Pharmaceutical composition for treating a metabolic syndromeSOMMERFELD MARK·Filed 2011·Application pending·0 cites
- 4647US2015231210A1Pharmaceutical Composition for Treating a Metabolic SyndromeSANOFI SA·Filed 2015·Application pending·0 cites
- 4746US2018057597A1Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123SANOFI SA·Filed 2017·Application pending·0 cites
- 4845US11254737B2Multispecific binding molecules having specificity to dystroglycan and laminin-2SANOFI SA·Filed 2020·Granted Feb 22, 2022·0 cites·38 claims
- 4943US2013344074A1Uses of a dual v region antibody-like proteinBENDER FLORENT·Filed 2012·Application pending·0 cites
- 5042US2009111744A1Human Growth Gene and Short Stature Gene RegionRAPPOLD-HOERBRAND GUDRUN·Filed 2007·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →